Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-27

Clinical Trial Update: VEGF-targeted Fluorescent Tracer Imaging in Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating a VEGF-targeted fluorescent tracer for imaging breast cancer has completed. The sponsor is University Medical Center Gronin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Medical Center Groningen | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED